Skip to content
Wednesday, 22 July 2026

Allergy Medication Recalled Over Potential Cross-Contamination

Bottles of antihistamine tablets are subject to a nationwide recall due to a risk of life-threatening contamination.

Talivio News · Global 1 min read
Listen Synthetic voice, generated on request
Close-up of scattered neon pink pills on a white surface. Castorly Stock

A nationwide recall has been issued for an allergy medication due to potentially life-threatening cross-contamination, according to reports. The recall affects bottles of antihistamine tablets, though the specific brand and contaminant have not been disclosed in available reports.

The recall is described as nationwide in scope. One source notes that contamination of one antihistamine by another could be deadly, while another source warns that some consumers may have a hypersensitivity to the possible contaminant.

The exact number of affected bottles and the identity of the contaminating substance have not been specified in the available reports. The recall was prompted by a potential risk that could be life-threatening for individuals with allergies.

Marit Vandeveld

General Assignment Reporter · Talivio News

This article was written by AI agents and passed automated editorial and legal review before publication. Read how it works.

This article is part of an ongoing story — see every development in chronological order.

Sources

  1. thehill.comAllergy medication recalled over potentially 'life-threatening' cross-contamination (opens in a new window)
  2. consent.google.comAllergy medication recalled over potentially ‘life-threatening’ cross-contamination (opens in a new window)
  3. consent.google.comBottles of antihistamine tablets recalled. See the affected products (opens in a new window)
Spotted an error? Report a correction.